首页 > 市场调查报告书 > 医疗设备

抛弃式

市场调查报告书

商品编码

1654729

英国外科手术用垫片市场 - 2025 至 2033 年

U.K. Surgical Pledgets Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年英国手术棉片市场规模达到 1,350 万美元，预计到 2033 年将达到 2,090 万美元，在 2025-2033 年预测期内的复合年增长率为 5.4%。

手术缝合垫是外科手术过程中用来提高缝合效果的专用医疗设备。它们是不可吸收的合成贴片，主要由聚四氟乙烯 (PTFE) 製成。这些贴片通常很小、很扁平、很有弹性，设计用于在手术过程中放置在缝线下方。

手术垫的主要用途是作为缝合线支撑。当缝合线应用于脆弱的组织时，缝合线施加的张力可能会导致周围组织撕裂或受损。缝合线透过将缝合线的张力分散到更大的区域来帮助减轻这种风险。这种更广泛的分布减少了组织上的局部压力，从而保护其免受拉伤和潜在伤害。这些因素推动了英国手术用棉片市场的扩张。

市场动态：

驱动因素与约束因素

外科技术的进步

手术技术的进步是英国手术棉片市场成长的关键驱动力，显着提高了手术棉片的有效性、安全性和应用性。材料科学的最新创新导致了用于手术垫的先进合成材料的开发，例如聚四氟乙烯（PTFE）和其他生物相容性聚合物。这些材料表现出低组织反应性和高耐久性，使其成为外科手术应用的理想选择。

现代手术环境越来越多地采用机器人辅助手术和增强成像系统等技术。手术敷料被设计成与这些系统无缝集成，从而实现更精确的放置和更好的结果。这种技术整合提高了手术过程的整体效果。所有这些因素都对英国手术用棉片市场提出了要求。此外，对微创手术的需求不断增长，促进了英国手术棉片市场的扩张。

手术垫料成本高昂

手术棉片的高成本是英国手术棉片市场的重大限制因素，对医疗保健提供者和患者都产生影响。手术用棉条的价格昂贵，这对医院和外科中心来说是一个财务挑战，特别是那些预算有限的医院和外科中心。当面临高昂成本时，这些机构可能会优先考虑基本医疗用品，而不是诸如棉垫之类的专用物品，这可能会影响手术期间这些物品的可用性。

费用上涨可能会限制患者接受必要的手术。如果医疗机构无法负担这些费用，他们可能会将其转嫁给患者，从而降低手术费用。这种经济障碍可能会阻止患者及时寻求手术干预，导致治疗延误和健康恶化。

手术缝合垫的高成本可能导致医疗保健提供者考虑其他伤口闭合方法，例如手术缝合器或胶带，这些方法被认为是更具成本效益的选择。由于供应商选择更适合其预算限制的替代品，这种偏好的转变可能会阻碍手术棉片市场的成长。因此，上述因素可能会限制英国手术棉片市场的潜在成长。

Surgical pledgets are specialized medical devices utilized in surgical procedures to improve the effectiveness of sutures. They are non-absorbable synthetic patches primarily constructed from polytetrafluoroethylene (PTFE). These patches are typically small, flat, and resilient and are designed to be placed beneath sutures during surgical interventions.

The main purpose of surgical pledgets is to serve as suture supports. When sutures are applied to delicate tissues, there is a risk that the tension exerted by the sutures may cause tearing or damage to the surrounding tissue. Pledgets help alleviate this risk by distributing the tension of the sutures over a wider area. This broader distribution reduces localized pressure on the tissue, thereby protecting it from strain and potential injury. These factors have driven the U.K. surgical pledgets market expansion.

Market Dynamics: Drivers & Restraints

Advancements in Surgical Technologies

Advancements in surgical technologies are a crucial driver of growth in the U.K. surgical pledgets market, significantly enhancing their effectiveness, safety, and application. Recent innovations in materials science have led to the development of advanced synthetic materials for surgical pledgets, such as polytetrafluoroethylene (PTFE) and other biocompatible polymers. These materials exhibit low tissue reactivity and high durability, making them ideal for surgical applications.

Modern surgical environments are increasingly incorporating technologies such as robotic-assisted surgery and enhanced imaging systems. Surgical pledgets are being designed to integrate seamlessly with these systems, allowing for more precise placement and improved outcomes. This technological integration enhances the overall efficacy of surgical procedures. All these factors demand the U.K. surgical pledgets market. Moreover, the growing demand for minimally invasive surgeries contributes to the U.K. surgical pledgets market expansion.

High Cost of Surgical Pledgets

The high cost of surgical pledgets is a significant constraint in the U.K. surgical pledgets market, impacting both healthcare providers and patients. The substantial price of surgical pledgets presents a financial challenge for hospitals and surgical centers, especially those operating with limited budgets. When confronted with high costs, these facilities may prioritize essential medical supplies over specialized items like pledgets, potentially affecting their availability during surgeries.

Elevated costs can restrict patient access to necessary surgical procedures. If healthcare facilities are unable to absorb these expenses, they may pass them on to patients, making surgeries less affordable. This financial barrier can deter patients from seeking timely surgical interventions, leading to delays in treatment and worsening health outcomes.

The high cost of surgical pledgets may lead healthcare providers to consider alternative wound closure methods, such as surgical staplers or adhesive strips, which are perceived as more cost-effective options. This shift in preference could hinder the growth of the surgical pledgets market as providers opt for alternatives that better fit their budget constraints. Thus, the above factors could be limiting the U.K. surgical pledgets market's potential growth.

Segment Analysis

The U.K. surgical pledgets market is segmented based on type, material, application, end-user, and region.

Type:

The non-absorbable pledgets segment is expected to dominate the U.K. surgical pledgets market share

The non-absorbable pledgets segment holds a major portion of the U.K. surgical pledgets market share and is expected to continue to hold a significant portion of the U.K. surgical pledgets market share during the forecast period.

Non-absorbable pledgets are synthetic devices specifically designed to provide reinforcement and support to sutured tissues during surgical procedures. They are primarily made from materials such as Polytetrafluoroethylene (PTFE) known for their exceptional durability, low friction, and minimal tissue reactivity, making them suitable for long-term applications. Polyester is valued for its strength and compatibility with various surgical techniques. These materials are selected for their ability to withstand biological environments without degrading, ensuring their effectiveness throughout the healing process.

Non-absorbable pledgets hold a significant share of the U.K. surgical pledgets market due to their widespread adoption across various surgical specialties. Their durability and low risk of complications contribute to their popularity among healthcare providers.

Non-absorbable pledgets are utilized in several key areas of cardiac surgery they provide essential support during procedures such as aortic valve replacements and coronary artery bypass grafts, where maintaining suture integrity is critical. Thoracic surgery is used to reinforce sutures in lung surgeries, ensuring stability and minimizing complications. General surgery is employed in diverse surgical procedures to enhance suture performance and reduce tissue damage.

The increasing prevalence of cardiovascular diseases among the aging population in the U.K. is driving demand for non-absorbable pledgets. As the geriatric demographic expands, so does the need for surgical interventions that utilize these devices. Innovations in material science are leading to the development of more effective non-absorbable pledget designs, enhancing their performance and broadening their applications across different surgical specialties. These factors have solidified the segment's position in the U.K. surgical pledgets market.

Competitive Landscape

The major players in the U.S. pollinosis market include Medtronic, B. Braun SE, Johnson & Johnson (Ethicon), Teleflex Incorporated., PetersSurgical, DeRoyal Industries, Inc., BD, Boz Medical, Advanced MedTech Solutions Pvt. Ltd, and Golnit among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The U.K. surgical pledgets market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Advancements in Surgical Technologies
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Surgical Pledgets
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Non-Absorbable Pledgets*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Absorbable Pledgets

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Polytetrafluoroethylene (PTFE)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polypropylene
7.4. Dacron
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiac Surgery*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Thoracic Surgery
8.4. General Surgery
8.5. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers (ASCs)
9.5. Others

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Medtronic *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
  - 11.1.2.1. Product Description
  - 11.1.2.2. Product Key Performance Indicators (KPIs)
  - 11.1.2.3. Historic and Forecasted Product Sales
  - 11.1.2.4. Product Sales Volume
- 11.1.3. Financial Overview
  - 11.1.3.1. Company Revenue's
  - 11.1.3.2. Geographical Revenue Shares
  - 11.1.3.3. Revenue Forecasts
- 11.1.4. Key Developments
  - 11.1.4.1. Mergers & Acquisitions
  - 11.1.4.2. Key Product Development Activities
  - 11.1.4.3. Regulatory Approvals etc.
- 11.1.5. SWOT Analysis
11.2. B. Braun SE
11.3. Johnson & Johnson (Ethicon)
11.4. Teleflex Incorporated.
11.5. PetersSurgical
11.6. DeRoyal Industries, Inc.
11.7. BD
11.8. Boz Medical
11.9. Advanced MedTech Solutions Pvt. Ltd
11.10. Golnit